Transgenomic transgenomic.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Transgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery, and laboratory testing services to the academic and medical research, clinical laboratory, and biopharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Their flagship product is ICE ...Show all

Transgenomic (NASDAQ:TBIO) is a global biotechnology company that advances personalized medicine in oncology and inherited diseases via its products and services for automated high-sensitivity genetic variation and mutation analysis. Their offerings ...Show all

Company (Alive / Active)

Phone: 402-452-5400

Fax:

12325 Emmet Street

Omaha, 68164
Nebraska, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Transgenomic $92.3M Oct 5, 2005
See all 25 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Transgenomic Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 25 competitors